EdgarLookup

Protagonist Therapeutics, Inc — SC 13G/A Filings

55 SC 13G/A filings on record

This page lists all SC 13G/A filings submitted to the SEC by Protagonist Therapeutics, Inc (PTGX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Protagonist Therapeutics, Inc has filed 55 SC 13G/A documents with the SEC since 2006. To view all SEC filings by Protagonist Therapeutics, Inc, see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-Q 144 3 4 4/A 424B3 424B4 424B5 5 8-A12B 8-A12B/A 8-K 8-K/A ARS CERTNAS CORRESP CT ORDER D DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT PRE 14A REGDEX S-1 S-1/A S-1MEF S-3 S-3ASR S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0000921895-24-002719 Nov 14, 2024
SC 13G/A 0000932471-24-001157 Nov 12, 2024
SC 13G/A 0000932471-24-000563 Nov 4, 2024
SC 13G/A 0001086364-24-008384 Aug 7, 2024
SC 13G/A SC 13G/A 0001104659-24-023959 Feb 14, 2024
SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0000921895-24-000437 Feb 14, 2024
SC 13G/A PROTAGONIST THERAPEUTICS, INC. 0000902664-24-001573 Feb 14, 2024
SC 13G/A PROTAGONIST THERAPEUTICS, INC. 0000902664-24-001553 Feb 14, 2024
SC 13G/A SCHEDULE 13G/A 0001104659-24-021763 Feb 13, 2024
SC 13G/A PROTAGONIST THERAPEUTICS, INC. 0000902664-24-001166 Feb 7, 2024
SC 13G/A 0000908834-24-000035 Feb 2, 2024
SC 13G/A 0001086364-24-002344 Jan 24, 2024
SC 13G/A SCHEDULE 13G/A, AMENDMENT #2 0000899140-23-000381 Feb 14, 2023
SC 13G/A PROTAGONIST THERAPEUTICS, INC. 0000902664-23-001711 Feb 14, 2023
SC 13G/A AMENDMENT NO. 6 TO THE SCHEDULE 13G 0000921895-23-000478 Feb 14, 2023
SC 13G/A 0001175707-23-000047 Feb 9, 2023
SC 13G/A 0001306550-23-005158 Jan 31, 2023
SC 13G/A 0000315066-22-001871 Dec 12, 2022
SC 13G/A 0000315066-22-001626 Jun 10, 2022
SC 13G/A SCHEDULE 13G/A, AMENDMENT #1 0000899140-22-000317 Feb 14, 2022
SC 13G/A CONSONANCE CAPITAL MANAGEMENT LP 0001085146-22-001037 Feb 14, 2022
SC 13G/A PROTAGONIST THERAPEUTICS, INC 0000902664-22-001579 Feb 14, 2022
SC 13G/A AMENDMENT NO. 5 TO THE SCHEDULE 13G 0000921895-22-000451 Feb 14, 2022
SC 13G/A AMENDMENT #4 0000908834-22-000091 Feb 11, 2022
SC 13G/A 0000315066-22-001301 Feb 9, 2022
SC 13G/A 0000834237-22-005353 Feb 3, 2022
SC 13G/A AMENDMENT NO. 4 TO THE SCHEDULE 13G 0000921895-21-000409 Feb 16, 2021
SC 13G/A AMENDMENT NO. 3 0001214659-21-001721 Feb 16, 2021
SC 13G/A 0001493152-21-003507 Feb 12, 2021
SC 13G/A PROTAGONIST THERAPEUTICS, INC. 0000902664-21-001142 Feb 11, 2021
SC 13G/A 0000315066-21-001243 Feb 8, 2021
SC 13G/A 0000834237-20-009556 Jun 9, 2020
SC 13G/A SCHEDULE 13G/A 0001104659-20-021728 Feb 14, 2020
SC 13G/A SC 13G/A 0001193125-20-038117 Feb 14, 2020
SC 13G/A AMENDMENT NO. 3 TO THE SCHEDULE 13G 0000921895-20-000521 Feb 14, 2020
SC 13G/A 0001493152-20-002364 Feb 14, 2020
SC 13G/A AMENDMENT NO. 2 0001214659-20-001392 Feb 14, 2020
SC 13G/A 0000315066-20-001141 Feb 7, 2020
SC 13G/A SC 13G/A 0001193125-19-040996 Feb 14, 2019
SC 13G/A 0000930413-19-000575 Feb 14, 2019
SC 13G/A AMENDMENT NO. 2 TO THE SCHEDULE 13G 0000921895-19-000465 Feb 14, 2019
SC 13G/A AMENDMENT NO. 1 0001214659-19-001113 Feb 14, 2019
SC 13G/A PROTAGONIST THERAPEUTICS, INC 0000902664-19-000928 Feb 13, 2019
SC 13G/A 0000315066-19-001298 Feb 13, 2019
SC 13G/A AMENDMENT NO. 2 0001193125-19-028285 Feb 5, 2019
SC 13G/A SC 13G/A 0001193125-19-015661 Jan 24, 2019
SC 13G/A AMENDMENT NO. 1 TO THE SCHEDULE 13G 0000921895-18-002281 Aug 10, 2018
SC 13G/A SC 13G/A 0001193125-18-050654 Feb 21, 2018
SC 13G/A 0000315066-18-001489 Feb 13, 2018
SC 13G/A AMENDMENT NO. 1 0000950142-18-000336 Feb 7, 2018